Product Information

TRIFLUOPERAZINE 1 MG TABLET is a generic product labeled by Sandoz Inc., priced at $0.4047 per EA under NDC 00781802801. Its NADAC has been published 149 times since Mar 13, 2019.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TRIFLUOPERAZINE 1 MG TABLET

Trifluoperazine Hydrochloride
$0.4047per EA

Strength

1 mg/1

Manufacturer

Sandoz Inc.

NDC

00781802801

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA085785

FDA Approved

Before 1982

TE Code

AB

On Market Since

11/20/1981

Pharmacological Classes

Phenothiazine
Phenothiazines

Price Statistics

The NADAC for TRIFLUOPERAZINE 1 MG TABLET has been published 149 times since Mar 13, 2019, and over the history we have for it it has declined 25.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4047 per EA
All-time high$0.5449 (Jun 12, 2019)
All-time low$0.3623 (Feb 18, 2026)
52-week high$0.4358
52-week low$0.3623
Median price$0.4700
Average price$0.4585
Largest weekly change-12.4% (Apr 17, 2024)
Weeks tracked149
Tracking sinceMar 13, 2019

Price History

1W

0.0%

1M

-4.8%

3M

-6.5%

6M

+0.9%

1Y

-1.7%

3Y

-25.7%

5Y

-25.7%

All

-25.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Trifluoperazine Hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TRIFLUOPERAZINE 1 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TRIFLUOPERAZINE 1 MG TABLET, manufactured by Sandoz Inc., is $0.4047 per EA (NDC 00781802801), effective Nov 11, 2026.

How has the price of TRIFLUOPERAZINE 1 MG TABLET changed over time?

Over the history we have for it, the NADAC for TRIFLUOPERAZINE 1 MG TABLET has declined 25.7%. It has been tracked across 149 weekly CMS publications since Mar 13, 2019.

What are the highest and lowest recorded NADAC prices for TRIFLUOPERAZINE 1 MG TABLET?

Since Mar 13, 2019, the NADAC for TRIFLUOPERAZINE 1 MG TABLET has ranged from a low of $0.3623 (Feb 18, 2026) to a high of $0.5449 (Jun 12, 2019), with a median of $0.4700 per EA.

Are there cheaper alternatives to TRIFLUOPERAZINE 1 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of TRIFLUOPERAZINE 1 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures TRIFLUOPERAZINE 1 MG TABLET?

TRIFLUOPERAZINE 1 MG TABLET (NDC 00781802801) is labeled by Sandoz Inc., and CMS classifies it as a generic product.